BNP Paribas Financial Markets’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-12,542
Closed -$253K 3594
2021
Q3
$253K Buy
12,542
+9,942
+382% +$200K ﹤0.01% 2387
2021
Q2
$97K Sell
2,600
-11,517
-82% -$430K ﹤0.01% 2461
2021
Q1
$361K Sell
14,117
-324,870
-96% -$8.31M ﹤0.01% 2214
2020
Q4
$7.47M Buy
338,987
+219,765
+184% +$4.84M 0.01% 624
2020
Q3
$2.14M Buy
119,222
+106,795
+859% +$1.92M ﹤0.01% 1063
2020
Q2
$316K Sell
12,427
-24,749
-67% -$629K ﹤0.01% 1704
2020
Q1
$683K Sell
37,176
-30,924
-45% -$568K ﹤0.01% 1650
2019
Q4
$1.5M Buy
68,100
+59,685
+709% +$1.31M ﹤0.01% 1297
2019
Q3
$121K Buy
8,415
+2,442
+41% +$35.1K ﹤0.01% 2408
2019
Q2
$94.1K Sell
5,973
-5,204
-47% -$82K ﹤0.01% 2462
2019
Q1
$164K Buy
+11,177
New +$164K ﹤0.01% 2241
2018
Q4
Sell
-1,452
Closed -$22.2K 3752
2018
Q3
$22.2K Sell
1,452
-154
-10% -$2.35K ﹤0.01% 2706
2018
Q2
$19.7K Buy
1,606
+1,574
+4,919% +$19.3K ﹤0.01% 2859
2018
Q1
$306 Hold
32
﹤0.01% 3537
2017
Q4
$289 Hold
32
﹤0.01% 3439
2017
Q3
$184 Hold
32
﹤0.01% 3483
2017
Q2
$101 Hold
32
﹤0.01% 3526
2017
Q1
$109 Hold
32
﹤0.01% 3403
2016
Q4
$92 Buy
+32
New +$92 ﹤0.01% 3415
2016
Q1
Sell
-3,156
Closed -$37.5K 3228
2015
Q4
$37.5K Buy
3,156
+32
+1% +$380 ﹤0.01% 3002
2015
Q3
$25.6K Buy
3,124
+1,868
+149% +$15.3K ﹤0.01% 3232
2015
Q2
$17.5K Buy
1,256
+1,182
+1,597% +$16.5K ﹤0.01% 3126
2015
Q1
$1.78K Buy
+74
New +$1.78K ﹤0.01% 3489
2014
Q4
Sell
-167
Closed -$2.13K 2998
2014
Q3
$2.13K Buy
167
+94
+129% +$1.2K ﹤0.01% 3404
2014
Q2
$1.65K Buy
+73
New +$1.65K ﹤0.01% 2732